Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1Gynecologic 1

Conditions

Diffuse Intrinsic Pontine Glioma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Obesity 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Glioma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Disease 1Carcinosarcoma 1

Interventions

Tirzepatide 5semaglutide 2Observation 2Metformin 2Exercise 2Counseling 2mirabegron 1atezolizumab 1Weights and Measures 1Walk Test 1Trehalase 1Therapeutics 1Tablets 1TIC10 compound 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Resistance Training 1Progestins 1Pregabalin 1Population Groups 1Omeprazole 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Methods 1Metabolic Networks and Pathways 1Liraglutide 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Obesity × TIC10 compound × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡